{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:45:12Z","timestamp":1780735512840,"version":"3.54.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 54-year-old man with metastatic well-differentiated neuroendocrine tumor of the pancreas underwent <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT scan to evaluate treatment response. Patient was known for remote history of chronic lymphocytic leukemia (CLL), previously treated. Scan revealed diffusely increased abnormal tracer uptake throughout the marrow of the axial and proximal appendicular skeleton. Bone marrow biopsy revealed relapsed CLL. We present a rare case of relapsed CLL incidentally detected on <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004386","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T16:02:25Z","timestamp":1673020945000},"page":"e78-e79","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["68Ga-DOTATATE PET\/CT Incidentally Detects Relapsed Chronic Lymphocytic Leukemia in Patient With Metastatic Neuroendocrine Tumor"],"prefix":"10.1097","volume":"48","author":[{"given":"Yazan Z.","family":"Alabed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00259-010-1512-3","article-title":"Procedure guidelines for PET\/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00259-003-1255-5","article-title":"DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals","volume":"30","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1097\/RLU.0000000000001620","article-title":"68Ga-DOTATATE PET\/CT in nonneuroendocrine tumors: a pictorial essay","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","year":"2015","journal-title":"Radiographics"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.1993.tb04634.x","article-title":"Somatostatin analogue scintigraphy of malignant lymphomas","volume":"83","year":"1993","journal-title":"Br J Haematol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.semnuclmed.2005.03.001","article-title":"Initial staging of lymphoma with octreotide and other receptor imaging agents","volume":"35","year":"2005","journal-title":"Semin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1365-2141.2001.02583.x","article-title":"Somatostatin receptor scintigraphy useful in stage I\u2013II Hodgkin\u2019s disease: more extended disease identified","volume":"112","year":"2001","journal-title":"Br J Haematol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/0284186X.2017.1342864","article-title":"Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at 68Ga-DOTANOC PET\/CT imaging","volume":"57","year":"2018","journal-title":"Acta Oncol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4274\/mirt.galenos.2021.37268","article-title":"Physiological biodistribution of 68Ga-DOTA-TATE in normal subjects","volume":"30","year":"2021","journal-title":"Mol Imaging Radionucl Ther"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:01:53Z","timestamp":1750536113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004386","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,6]]}}}